Botswana vs South-East Asia (WHO region): Treatment success rate: XDR-TB cases
Botswana
100
in 2021
South-East Asia (WHO region)
73
in 2022
Botswana rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate: XDR-TB cases over time
- Botswana
- South-East Asia (WHO region)
How they compare
Botswana currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Botswana's figure about 1.4 times South-East Asia (WHO region)'s.
Across all 5 years both countries report, Botswana has been ahead every year.
Botswana ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
Botswana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Botswana | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.25 | 32.5 | 46.75 | Botswana |
| 2020s | 100 | 70 | 30 | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Botswana or South-East Asia (WHO region)?
- Botswana, at 100 against 73 in South-East Asia (WHO region) as of 2021.
- What is the difference in treatment success rate: xdr-tb cases between Botswana and South-East Asia (WHO region)?
- 27, with Botswana ahead.
- How many years of comparable data are there for Botswana and South-East Asia (WHO region)?
- 5 years are reported by both, from 2011 to 2021.
- How do Botswana and South-East Asia (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Botswana ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.